A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19

We report a fatal case of Rhizopus azygosporus pneumonia in a 56-year-old man hospitalized for COVID-19 who had received methylprednisolone and tocilizumab. Although COVID-associated pulmonary aspergillosis has been widely documented, mucormycosis has been rarely reported. In this patient, receipt of two commonly used immunosuppressants likely contributed to mucormycosis risk, suggesting the need for vigilance in hospitalized patients with COVID-19.

• Publication year

  2021

• Venue

  Journal of Fungi

• Publication date

  2021-02-28

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.3390/jof7030174PMID 33670842PMCID 7997212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

  2020influential reference
• Rhino-Orbital Mucormycosis Associated With COVID-19

  2020cited by this paper
• Aspergillosis Complicating Severe Coronavirus Disease

  2020cited by this paper
• Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report

  2020cited by this paper
• Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome.

  2020cited by this paper
• A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis

  2020cited by this paper
• Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

  2020cited by this paper
• Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study

  2020cited by this paper
• A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU

  2020cited by this paper
• Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19)

  2020cited by this paper
• Mucormycosis with orbital compartment syndrome in a patient with COVID-19

  2020cited by this paper
• Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia

  2020cited by this paper
• Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis

  2016cited by this paper
• Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis).

  2012cited by this paper
• Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients.

  2011cited by this paper
• Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

  2005cited by this paper
• Non-commercial Research and Educational Use including without Limitation Use in Instruction at Your Institution, Sending It to Specific Colleagues That You Know, and Providing a Copy to Your Institution's Administrator. All Other Uses, Reproduction and Distribution, including without Limitation Comm

  year unknowninfluential reference

• Uncovering the Predisposing Factors of Mucormycosis: Insights from Systematic Review

  2025cites this paper
• Non-Neoformans Cryptococcal Infections in the Post-Coronavirus Disease-19 (COVID-19) Era: Are We Ready to Face the Emerging Challenge?

  2024cites this paper
• Mucormycosis: An Emerging Fungal Infection in the COVID-19 Pandemic

  2024cites this paper
• Nanotechnology-Based Strategies for Combating Emerging and Re-emerging Fungal Infections

  2024cites this paper
• Corona-Associated Mucormycosis: Case Series Reports and Review of the Literature

  2024cites this paper
• Clinicoradiological Profile of COVID-19–Associated Rhino-Orbital Cerebral Mucormycosis with a Focus on Computed Tomography: A Clinical Case Series and Review

  2023cites this paper
• COVID-19 and Mucormycosis of Orofacial Region: A Scoping Review

  2023influential citation
• Surge of mucormycosis during the COVID-19 pandemic

  2023influential citation
• Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review.

  2023cites this paper
• Surge of mucormycosis during the COVID-19 pandemic

  2023influential citation
• An Update on COVID‐19 Associated Mucormycosis Characteristics, Risk Factors, and Outcomes: a Systematic Review and Meta-Analysis

  2023cites this paper
• Development of a monoclonal antibody and a lateral-flow device for the rapid detection of a Mucorales-specific biomarker

  2023cites this paper
• Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review

  2023cites this paper
• Review COVID-19 and Fungal infections: a double debacle and

  2022cites this paper
• COVID-19 associated mucormycosis – An emerging threat

  2022cites this paper
• SARS-CoV-2 in Kidney Transplant Recipients: A Systematic Review

  2022cites this paper
• The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

  2022cites this paper
• Rise of the Phoenix: Mucormycosis in the Context of COVID-19

  2022cites this paper
• Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach

  2022cites this paper
• Coincidence or reality behind Mucormycosis, diabetes mellitus and Covid-19 association: A systematic review

  2022cites this paper
• Covid-19 Infection and its Adverse Effects on Multiorgan

  2022cites this paper
• Mucormycosis infection in patients with COVID‐19: A systematic review

  2022cites this paper
• Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India

  2022cites this paper
• An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic?

  2022cites this paper
• COVID-19 associated pulmonary mucormycosis: A systematic review of published cases with review of literature

  2022cites this paper
• A Comprehensive Review on the Management of COVID-19-Associated Mucormycosis (CAM): The New Basics

  2022cites this paper
• Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis

  2022cites this paper
• COVID-19-Associated Fungal Infections: An Urgent Need for Alternative Therapeutic Approach?

  2022cites this paper
• Bronchial wall necrosis secondary to mucormycosis following SARS-Cov2 infection: A case report

  2022cites this paper
• A systematic review of mucormycosis cases in COVID-19: Is it an unholy trilogy of COVID-19, diabetes mellitus, and corticosteroids?

  2022cites this paper
• Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review

  2022cites this paper
• COVID-19-associated fungal infections in Iran: A systematic review

  2022cites this paper
• The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review

  2022cites this paper
• Mucormycosis co-infection in COVID-19 patients: An update

  2022cites this paper
• Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: a systematic review and meta-analysis

  2022cites this paper
• Comparative risk assessment of COVID‐19 associated mucormycosis and aspergillosis: A systematic review

  2022cites this paper
• COVID-19 and Fungal infections: a double debacle

  2022cites this paper
• COVID-19 associated rhinomaxillary mucormycosis

  2022cites this paper
• Covid 19 and opportunism of Mucormycosis

  2022cites this paper
• Dual Fungal Infection of Aspergillosis and Mucormycosis in a COVID-19 Patient: A Rare Case Report

  2022cites this paper
• Mucormycosis and COVID-19: A systemic review

  2022cites this paper
• Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single centre experience from Pune, Western India

  2022cites this paper
• The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review following aspergillosis in COVID-19 patients

  2022cites this paper
• Review COVID-19 and Fungal infections: a double debacle and

  2022cites this paper
• Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients

  2021cites this paper
• A systematic review on SARS‐CoV‐2‐associated fungal coinfections

  2021cites this paper
• COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping

  2021influential citation
• COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors

  2021cites this paper
• COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management

  2021cites this paper
• Invasive Fungal Infections Complicating COVID-19: A Narrative Review

  2021cites this paper
• In Silico Designing of a Multitope Vaccine against Rhizopus microsporus with Potential Activity against Other Mucormycosis Causing Fungi

  2021cites this paper
• Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature

  2021influential citation
• Mucormycosis and Candida Infections in Patients of COVID-19 Pneumonia: A Systematic Review

  2021cites this paper
• Mucormycosis in COVID-19: A systematic review of literature.

  2021cites this paper
• New insights on mucormycosis and its association with the COVID-19 pandemic

  2021cites this paper
• Mucormycosis following COVID19: clinical case and literature review

  2021cites this paper
• COVID-19 Associated Rhino-Orbital Mucormycosis Complicated by Gangrenous and Bone Necrosis—A Case Report from Honduras

  2021cites this paper
• COVID-19-associated mucormycosis: Case report and systematic review

  2021cites this paper
• Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World

  2021cites this paper
• Epidemiology, clinical presentation and management of COVID-19 associated Mucormycosis: A single center experience from Pune, Western India.

  2021cites this paper
• COVID-19 and mucormycosis superinfection: the perfect storm

  2021cites this paper
• Mucormycosis and COVID‐19: An epidemic within a pandemic in India

  2021cites this paper
• Mucormycosis - The black menace in COVID-19

  2021cites this paper
• Mucormycosis: An opportunistic pathogen during COVID-19

  2021cites this paper
• COVID‐19‐associated mucormycosis: An updated systematic review of literature

  2021cites this paper
• COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

  2021cites this paper
• Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India

  2021cites this paper
• Mucormycosis in Indian COVID-19 Patients: Insight into Its Patho-Genesis, Clinical Manifestation, and Management Strategies

  2021cites this paper
• The ‘black fungus’ Co-Infection in COVID-19 Patients : A Review

  2021cites this paper
• Rising concerns of Mucormycosis (Zygomycosis) among COVID-19 patients; an analysis and review based on case reports in literature

  2021cites this paper
• A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update

  2021cites this paper
• High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections

  2021cites this paper
• CT Findings of COVID-19–associated Pulmonary Mucormycosis: A Case Series and Literature Review

  2021cites this paper
• A Systematic Review of SARS-CoV-2 in Kidney Transplant Recipients

  year unknowncites this paper